Xylone Paediatric Nasal Drops contain Xylometazoline 0.05% w/v, a topical nasal decongestant indicated for the relief of nasal congestion associated with common cold, allergic rhinitis, and sinusitis in children. Xylometazoline acts as a selective alpha-adrenergic receptor agonist, causing vasoconstriction of the nasal mucosal blood vessels, thereby reducing swelling and promoting nasal airway patency. The formulation is specifically designed for paediatric use, ensuring appropriate dosing and safety for infants and young children. Administration is typically limited to a maximum of three to five days to prevent rebound congestion or rhinitis medicamentosa. The drops should be used with caution in patients with hypertension, cardiovascular disorders, hyperthyroidism, or diabetes, and are contraindicated in cases of hypersensitivity to Xylometazoline or any excipients. Common adverse effects may include transient nasal irritation or dryness. It is essential to adhere to recommended dosages and duration to minimize potential systemic absorption and side effects. Xylone Paediatric Nasal Drops provide rapid symptomatic relief, improving breathing comfort and sleep quality in affected children. Consultation with a healthcare professional is advised prior to use, especially in cases of persistent or worsening symptoms.